Page last updated: 2024-11-03

probucol and Cardiotoxicity

probucol has been researched along with Cardiotoxicity in 1 studies

Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.

Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mooranian, A1
Zamani, N1
Takechi, R1
Luna, G1
Mikov, M1
Goločorbin-Kon, S1
Elnashar, M1
Arfuso, F1
Al-Salami, H1

Other Studies

1 other study available for probucol and Cardiotoxicity

ArticleYear
An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques.
    PloS one, 2019, Volume: 14, Issue:4

    Topics: Administration, Oral; Animals; Capsules; Cardiotoxicity; Diabetes Mellitus, Experimental; Diabetes M

2019